Publication | Closed Access

Targeting ESE3/EHF With Nifurtimox Inhibits CXCR2+ Neutrophil Infiltration and Overcomes Pancreatic Cancer Resistance to Chemotherapy and Immunotherapy

Cancer ImmunosurveillancePancreatic CancerMedicineImmunologyImmune Checkpoint InhibitorImmunotherapyOncologyRadiation OncologyTumor MicroenvironmentCancer Research